High Quality IVF Center in Israel – The Affordable Solution for Overseas Patients

List of Peer-Reviewed Publications

  • Weiner F, Kanter Y, Kol S, Barzilai D. Computer implementation of the new diabetes classification scheme. Meth Inform Med 21:191, 1982. Full text
  • Kanter Y, Kol S, Weiner F. Intravenous glucose tolerance test in gestational diabetes and pregnancy: manual vs. computerized assessment. Eur J Obstet Gynecol Reprod Biol. 27:307, 1988. Full text
  • Barnea ER, Fares F, Kol S. Stimulatory effect of prolactin on human placental progesterone secretion at term in vitro: possible inhibitory effect on estradiol secretion. Placenta 10:37, 1989.
  • Barnea ER, Perlman R, Fakih H, Bick T, Kol S, Hochberg Z. The role of catecholamines in estradiol and progesterone secretion by cultured explants and cells of human term placenta. Acta Endocrinologica 121:767, 1989. Full text
  • Barnea ER, Simon RJ, Kol S, Human embryonal extracts modulate placental function in the first trimester: effect of visceral tissues upon chorionic gonadotropin and progesterone secretion. Placenta 10:331, 1989.
  • Kol S, Gal D, Friedman M, Paldi E. Case report: preoperative diagnosis of fallopian tube carcinoma by TVS and CA-125. Gynecologic Oncology 37:129, 1990. Full text
  • Kol S, Jakobi P, Paldi E. The intrauterine device, a transitional period. Harefua 118:676, 1990.Full text
  • Adir Y, Bitterman H, Kol S, Melamed Y. Hyperbaric oxygen treatment for carbon monoxide intoxication acquired in the sealed room during the Persian Gulf War. Israel Journal of Medical Sciences 27:669, 1991. Full text
  • Barnea ER, Ashkenazy R, Tal Y, Kol S, Sarne Y. Effect of b-endorphin on human chorionic gonadotrophin secretion by placental explants. Hum Reprod 6: 1327, 1991.
  • Jakobi P, Kol S, Weissman A, Krivoy N. Peripartum changes in free and protein bound digoxin like immuno-reactive factor. J Reprod Med 37:127, 1992.
  • Adir Y, Kol S, Melamed Y. Carbon monoxide and coronary artery disease. Harefuah, 122:249, 1992. Full text
  • Nachum Z, Kol S, Adir Y, Melamed Y. Massive air embolism – a possible cause of death after operative hysteroscopy using a 32% dextran 70 pump. Fertil Steril 58:836, 1992. Full text
  • Kol S, Ammar R, Weisz G, Melamed Y. Hyperbaric oxygenation for arterial air embolism during cardiopulmonary bypass. Ann Thorac Surg, 55:401, 1993. Full text
  • Kol S, Weisz G, Melamed Y. Pulmonary barotrauma after a free dive – a possible mechanism. Aviat Space Environ Med 64:236, 1993. Full text
  • Kol S, Levron J, Lewit N, Drugan A, Itskovitz-Eldor J. The natural history of multiple pregnancies after assisted reproduction: Is spontaneous fetal reduction a clinically significant phenomenon? Fertil Steril 60:127, 1993. Full text
  • Kol S, Adir Y, Gordon CR, Melamed Y. Oxy-helium treatment of severe spinal decompression sickness after air diving. Undersea Biomed Res 20:147, 1993. Full text
  • Itskovitz-Eldor J, Levron J, Kol S. Use of GnRH-agonist to cause ovulation and prevent ovarian hyperstimulation sundrome. Clin Obstet Gynecol, 36:701, 1993. Full text
  • Aharon-Peretz J, Adir Y, Gordon CR, Kol S. Gal N, Melamed Y. Spinal Decompression sickness in sport diving. Arch Neurol 50:753, 1993. Full text
  • Kol S, Gordon CR, Melamed Y. The potential role of oxygen in the prevention of neurologic deficit after cardiac surgery. Intensive & Critical Care Digest 12:48, 1993. Full text
  • Payne DW, Shackeleton C, Toms H, Ben-Shlomo I, Kol S, deMoura M, Strauss JF, Adashi EY. A novel nonhepatic hydroxycholosterol 7ahydroxylase that is markedly stimulated by interleukin-1b J Biol Chem 270:18888-96, 1995. Full text
  • Kol S, Thaler I, Paz N, Shmueli O. Interpretation of nonstress tests by an artificial neural network. Am J Obstet Gynecol 172:1372, 1995. Full text
  •  Kol S, Ben-Shlomo I, Adashi EY, Rohan RM. Simplified riboprobe purification using starslucent straws as gel tubes. Gen Alalysis 1996;12:129-132. Full text
  •  Ben-Shlomo I, Kol S, Ando M, Altman KR, Putowski LT, Rohan RM, Adashi EY Ovarian expression, cellular localization, and hormonal regulation of rat secretory phospholipase A2: increased expression by interleukin-1 and by gonadotropins. Biol Reprod 1997;57:217-225. Full text
  •  Scherzer WJ, Putowski LT, Kol S, Adashi EY, Rohan RM. Detection and In Vitro Hormonal Regulation of Rat Ovarian Type I and Type II Interleukin-1 Receptor mRNA: Increased Expression During the Periovulatory Period. J Soc Gyn Invest 1996;3:131-9. Full text
  •  Kol S, Ben-Shlomo I, Ruutianen K, Ando M, Resnick CE, Rohan RM, Adashi EY.The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. J Clin Invest 1997, 99:2274-2283. Full text
  • Kol S, Ben-Shlomo I, Payne DW, Ando M, Rohan RM, Adashi EY. Glucocorticoids suppress basal (but not interleukin-1-supported) ovarian phospholipase A2 activity: evidence for glucocorticoid receptor-mediated regulation.Mol Cell Endocrinol 137:117-25, 1998 Full text
  •  Ben-Shlomo I, Kol S, Roeder LM, Resnick CE, Hurwitz A, Payne DW, Adashi EY. Interleukin (IL)-1b Increases Glucose Uptake and Induces Glycolysis in aerobically Cultured Rat Ovarian Cells: Evidence that IL-1b may Mediate the Gonadotropin-Induced Midcyle Metabolic Shift. Endocrinology 1997;138:2680-2688. Full text
  •  Kol S, Ben-Shlomo I, Ando M, Payne DW, Adashi EY. Interleukin-1b Stimulates Ovarian Phospholipase A2 (PLA2) Expression and Activity: Up-regulation of Both Secretory and Cystosolic PLA2. Endocrinology 1997;138: 314-321. Full text
  •  Kol S, Ruutiainen K, Ben-Shlomo I, Ando M, Payne DW, Adashi EY. The Rat Ovarian Phospholipase A2 System: Gene Expression, Cellular Localization, Activity Characterization, and Interleukin-1 Dependence. Endocrinology 1997;138:322-331. Full text
  • Kol S, Lewit N, Itskovitz-Eldor J. Ovarian Hyperstimulation Syndrome after using Gonadotropin-releasing Hormone Agonist as a Trigger of Ovulation: Causes and implications. Hum Reprod 11:1143, 1996. Full text
  • Lewit N, Kol S, Itskovitz-Eldor J. Does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome? Fertil Steril 66:654, 1996. Full text
  • Lewit N, Kol S, Manor D, Itskovitz-Eldor J. Comparison of GnRH Analogs And Hcg For The Induction of Ovulation And Preventation of Ovarian Hyperstimulation Syndrome (OHSS): A Case-control Study. Hum Reprod 11:1399, 1996. Full text
  •  Lewit N, Kol S, Manor D, Itskovitz-Eldor J. The Use of GnRH Analogues For the Induction of Preovulatory Gonadotropin Surge In Assisted Reproduction and Prevention of Ovarian Hyperstimulation Syndrome. Gynecol Endocrinol 9 (Suppl) 4:13-17, 1995. Full text
  •  Lightman A, Kol S, Wayner V, Vertman D, Manor D, Itskovitz-Eldor J. The presence of a sponsoring embryo in a batch of poor quality thawed embryos significantly increases pregnancy and implantation rate. Fertil Steril 67:711-6, 1997. Full text
  •  Kol S, Karnieli E, Kraiem Z, Itskovitz-Eldor J, Lightman A, Ish-Shalom S. Thyroid function in early normal pregnancy: transient suppression of thyroid stimulating hormone, and stimulation of triiodothyronine. Gyncol Obstet Invest 42:227-229, 1996. Full text
  •  Manor D, Kol S, Lewit N, Lightman A, Stein D, Pillar M, Itskovitz-Eldor J. Undocumented embryos: Do not trash them, FISH them. Hum Reprod 11:2502-2506, 1996. Full text
  •  Itskovitz-Eldor J, Filmar S, Manor D, Stein D, Lightman A, Kol S. Assisted implantation: Direct intra-endometrial embryo transfer. Gyncol Obstet Invest 43:73-75, 1997. Full text
  •  Kent-First MG, Kol S, Muallem A, Manor D, Blazer S, First N, Itskovitz-Eldor J. The incidence and possible relevance of Y-linked microdeletions in ICSI derived babies and their infertile fathers. Mol Hum Reprod 2:943-950, 1996. Full text
  • Itskovitz-Eldor J, Kol S, Lewit N, Sealey JE. Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 82:461-464, 1997. Full text
  •  Shupak A, Melamed Y, Ramon Y, Bentur Y, Abramovich A, Kol S. Helium and oxygen treatment of severe air diving-induced neurologic decompression sickness. Arch Neurol 54:305-311, 1997. Full text
  • Derman SG, Kol S, Ben-Shlomo I, Resnick CE, Rohan RM, Adashi EY. Transforming growth factor-beta1 is a potent inhibitor of interleukin-1beta action in whole ovarian dispersates. J Endocrinol 160:415-423, 1999. Full text
  • Kol S, Ben-Shlomo1 I, Ando M, Adashi1 EY. Insulin-like growth factor I affects the intraovarian interleukin-1 system: evidence for suppression of type I interleukin-1 receptor expression and enhancement of secretory phospholipase A2 expression and activity. Mol Hum Reprod 1997, 3:1095-1099. Full text
  • Ando M, Kol S, Kokia E, Ruutiainen-Altman K, Sirois J, Rohan RM, Payne DW, Adashi EY. Rat ovarian prostaglandin endoperoxide synthase-1 and -2: periovulatory expression of granulosa cell-based interleukin-1-dependent enzymes. Endocrinology 139:2501-8, 1998. Full text
  • Itskovitz-Eldor J, Kol S, Mannaerts B, Coelingh Bennink H. First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462). Hum Reprod 13:294-5, 1998. Full text
  • Kol S, Ben-Shlomo I, Ando M, Adashi EY. Insulin-like growth factor I affects the intraovarian interleukin-1 system: evidence for suppression of type I interleukin-1 receptor expression and enhancement of secretory phospholipase A2 expression and activity.Mol Hum Reprod 3:1095-9, 1997. Full text
  • Kol S, Donesky BW, Ruutiainen-Altman K, Ben-Shlomo I, Irahara M, Ando M, Rohan RM, Adashi EY. Ovarian Interleukin-1 Receptor Antagonist in Rats: Gene Expression, Cellular Localization, Cyclic Variation, and Hormonal Regulation of a Potential Determinant of Interleukin-1 Action. Biol Reprod 61:274-282, 1999. Full text
  • Kol S, Ruutiainen-Altman K, Scherzer WJ, Ben-Shlomo I, Ando M, Rohan RM, Adashi EY. The rat intraovarian interleukin (IL)-1 system: cellular localization, cyclic variation and hormonal regulation of IL-1beta and of the type I and type II IL-1 receptors. Mol Cell Endocrinol 149:115-28, 1999. Full text
  • Coffler MS, Kol S, Drugan A, Itskovitz-Eldor J Early transvaginal embryo aspiration: a safer method for selective reduction in high order multiple gestations. Hum Reprod 14:1875-1878, 1999. Full text
  • Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B, and Itskovitz-Eldor J. High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze–thaw cycles . Hum Reprod 14:2242-2244, 1999. Full text
  • Lightman A, Kol S, Itskovitz-Eldor J. A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles. Hum Reprod 14:2596-2599, 1999. Full text
  • Ando M, Kol S, Irahara M, Sirois J, Adashi EY. Non-steroidal anti-inflammatory drugs (NSAIDs) block the late, prostanoid-dependent/ceramide-independent component of ovarian IL-1 action: implications for the ovulatory process. Mol Cell Endocrinol 157:21-30, 1999. Full text
  • Irahara M, Ando M, Kol S, Adashi EY. Expression and hormonal regulation of rat ovarian interleukin-1beta converting enzyme, a putative apoptotic marker: endocrine- and aracrine-dependence. J Reprod Immunol 45:67-79, 1999. Full text
  • Kol S, Wong KH, Ando M, Ben-Shlomo I, Adashi EY. Rat ovarian interleukin-1alpha: interleukin-1-dependent in vitro expression. Endocrine 11:269-75, 1999. Full text
  • Kol S, Itskovitz-Eldor J. Severe OHSS: Yes, there is a strategy to prevent it! Hum Reprod 2000 Webtrack (1.8.2000). Full text
  • Kol S. GnRH antagonists in ART: lower embryo implantation? Hum Reprod; 5:1881-1882, 2000 Webtrack (12.6.2000). Full text
  • Lewit N, Kol S. The low responder female IVF patient with hypogonadotropic hypogonadism: do not give up! Fertil Steril 74:401-2, 2000. Full text
  • Beloosesky R, Kol S Lightman A, Itskovitz-Eldor J. Ovarian stimulation in in vitro fertilization with or without the “long” gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome. Fertil Steril 74:166-8, 2000. Full text
  • Itskovitz-Eldor J, Kol S Mannaerts B. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: Short communication. Hum Reprod 15:1965-1968, 2000. Full text
  • Kol S, Itskovitz-Eldor J. Severe OHSS: yes, there is a strategy to prevent it! Hum Reprod. 15:2266-7, 2000. Full text
  • Kol S, Should we explore OHSS full clinical scope?… Hum Reprod. 16:595-6, 2001. Full text
  • Kol S, Kehat I, Adashi EY. Ovarian interleukin-1-induced gene expression: privileged genes threshold theory. Med Hypotheses. 58:6-8, 2002. Full text
  • Nevo O, Eldar-Geva T, Kol S, Itskovitz-Eldor J. Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin. Fertil Steril 79:1123-8, 2003. Full text
  • Kol S. Vascular endothelial growth factor – mediator of PHSS? Fertil Steril 79:1466, 2003.Full text
  • Kol S. Prediction of ovarian hyperstimulation syndrome: why predict if we can prevent! Hum Reprod.18:1557-8. 2003. Full text
  • Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 81:1-5, 2004. Full text
  • Kol S, Muchtar M. Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further reseach. Reproductive BioMedicine Online 10:575-577, 2005. Full text
  • Kol S. To add or not to add LH: consideration of LH concentration changes in individual patients. Reproductive BioMedicine Online 11:664-666, 2005. Full text
  • Kol S, Solt I. GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy? Journal of Assisted Reproduction and Genetics 25:63-66, 2008. Full text
  • Kol S, Homburg R. Change, change, change: hormonal actions depend on changes in blood levels. Human Reproducion 23:1004-6, 2008. Full text
  • Kol S, Dor J. Prevention of OHSS: GnRH agonist versus HCG to trigger ovulation. Reproductive BioMedicine Online 19:59-60, 2009 Full text
  • Kol S, Humaidan P. LH (as hCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango. Reproductive BioMedicine Online 21:590-592, 2010 Full text
  • Kol S, Itskovitz-Eldor J. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome–a 20-year experience. Semin reorod Med 28:500-505, 2010 Full text
  • Humaidan P, Kol S and Papanikolaou EG, on behalf of the ‘The Copenhagen GnRH Agonist Triggering Workshop Group’. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Human eproduction Update 2011 ;17:510-524 Full text
  • Kol S, Humaidan P, Itskovitz-Eldor J. GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Hum. Reprod. 26:2874-77, 2011Full text
  • E.G Papanikolaou, P.Humaidan, N. Polyzos, S Kalantaridou, Kol S, C. Benadiva, H.Tournaye, B. Tarlatzis. New algorithm for OHSS prevention. Reproductive Biology and Endocrinology 2011, 9:14 Full text
  • P. Humaidan, Kol S, L. Engmann, C. Benadiva, E.G. Papanikolaou, and C. Yding Andersen, on behalf of the Copenhagen GnRH Agonist Triggering Workshop Group. Should Cochrane reviews be performed during the development of new concepts? Hum. Reprod. 27:6-8, 2012. Full text
  • Imbar T, Kol S, Lossos F, Bdolah Y, Hurwitz A, Haimov-Kochman R. Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support. Hum. Reprod. 27:753-9, 2012 Full text
  • Kol S, Homburg R, Alsbjerg B, Humaidan P.  The gonadotropin-releasing hormone antagonist protocol – the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.  ACTA Obstetrica et Gynecologica Scandinavica 91:643-7, 2012  Full text
  •  Sella T, Segal Y, Goren I, Chodick G, Shalev V, Homburg R, Bachar R, Kol S. In-Vitro fertilization cycles and outcomes in Maccabi Healthcare Services in Israel 2007-2010. Harefuah 152:11-14, 2013.  Full text
     See also
  •  Kol S, Humaidan P. GnRH agonist triggering: recent developments. Reproductive BioMedicine Online 26: 226– 230, 2013.  Full text
  • Mousavi Fatemi H, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, García-Velasco JA. Severe ovarian hyperstimulation after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze all” approach in GnRH antagonist protocol. Fertil Steril. 2014 Feb 14. Full text
  •  Kol S, Tannus S, Lightman A, Itskovitz J. Assisted reproductive technology in the presence of chronic viral disease. Harefuah 153:155-158, 2014.   Full text
  • Levron J, Zinchenko V, Kol S, Direnfeld M, Bider D. The use of portable CO2 incubator for cross-border shipping of embryos in an international egg donation program. Gynecol Endocrinol. 30:755-7, 2014.
  •  Kol S. Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol. Clinical Medicine Insights: Reproductive Health 8:59–64, 2014.  Full text

IVF at Israel

With unbeatable success rates and an affordable, competitive price, IVF treatment in Israel enjoys popularity and prestige among overseas patients.